From Medscape Diabetes & Endocrinology

Coverage from

Obesity Week 2017

October 29 - November 02, 2017; Washington, DC

October 29 - November 02, 2017 Washington, DC
  • ObesityWeek Antiobesity Drug Prescribing Rates Low and Stagnant Most eligible patients with obesity aren't receiving medication despite interest and increasing reimbursement. Of interest, primary-care practitioners are most likely to prescribe these agents.
  • ObesityWeek Overweight Binge Eaters Can Diet but Need Extra Help Although not a contraindication to referral for intensive lifestyle intervention programs, untreated binge eating may hinder weight loss.
  • ObesityWeek Bariatric Surgery: Many Can Come Off Insulin Long Term A retrospective follow-up finds 44% of obese patients with insulin-treated type 2 diabetes are able to stop insulin for 5 or more years after bariatric surgery.

Conference News

Popular News from Obesity Week 2016

  • Weight Loss Bumps Up Appetite More Than Threefold Weight Loss Bumps Up Appetite More Than Threefold Increased appetite is an even stronger driver of weight regain than slowed metabolism, novel research suggests. So medications that affect appetite may be important to prevent weight regain.
  • Quality Initiative Cuts Sleeve-Gastrectomy Readmissions Quality Initiative Cuts Sleeve-Gastrectomy Readmissions After a national quality-improvement program for bariatric surgery was implemented in 128 hospitals, 30-day hospital readmission rates fell, especially for sleeve gastrectomy. Postop information was key.
  • Enhanced Weight Watchers Program Tops Standard Diabetes Care Enhanced Weight Watchers Program Tops Standard Diabetes Care Patients with uncontrolled diabetes were more likely to attain diabetes control by attending a widely available commercial weight-loss program and receiving educational emails, compared with standard care.

Medscape Diabetes©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.